Neurizon Therapeutics
$0.15
5
+$0+0% Monday 12:05
Statistik
Harga Tertinggi Hari
-
Harga Terendah Hari
-
52M Tertinggi
-
52M Terendah
-
Volum
-
Volum Purata
-
Kapasiti Pasaran
0
Nisbah P/E
0
Pendapatan Dividen
-
Dividen
-
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti PAAFF. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Zai Lab Limited
ZLAB
Kapasiti Pasaran1.99B
Macrogenics
MGNX
Kapasiti Pasaran220.15M
Karyopharm Therapeutics
KPTI
Kapasiti Pasaran94.78M
TG Therapeutics
TGTX
Kapasiti Pasaran3.64B
Array Technologies
ARRY
Kapasiti Pasaran1.02B
Mengenai
Health Technology
Pharmaceuticals: Other
PharmAust Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. PharmAust Limited was incorporated in 2000 and is based in Melbourne, Australia.
Show more...
CEO
Dr. Michael Thurn Ph.D.
Negara
AU
ISIN
AU0000357261